PEOPLE - Shotwell & Carr (US) makes appointment:
This article was originally published in Clinica
Regulatory and clinical management service provider Shotwell & Carr (Dallas, Texas) has appointed Dennis Christiansen to lead its drive into the field of sterilisation requirements for medical devices and pharmaceuticals. The company has renamed itself as Shotwell Carr & Christiansen. The appointee, an engineering and microbiology expert, was previously sterilisation manager at Becton Dickinson.
You may also be interested in...
Approved in February as an on-demand remedy, Nurtec will be filed for migraine prevention after success in Phase III. It could be the first oral preventive therapy and first dual purpose migraine drug.
A protocol amendment is not needed to pause enrollment to decrease potential exposure to COVID-19, and virtual visits can be immediately implemented to ensure safety; experts say pandemic is forcing a rethinking in how companies carry out trials and in how regulators ensure patient safety and trial integrity.
South Korea’s Qurient achieves proof of concept in a Phase II study with its first-in-class antibiotic telacebec for tuberculosis and aims to file a US NDA for the orphan drug.